Quadrant Capital »

Autolus Therapeutics Plc spon ads shares owned by Quadrant Capital

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $20k 3.0k 6.44
2023-09-30 $7.0k 3.0k 2.33
2023-06-30 $7.2k 3.0k 2.38
2023-03-31 $7.1k 3.9k 1.84
2022-12-31 $1.6k 850 1.90
2022-09-30 $2.0k 921 2.17
2022-03-31 $13k 3.1k 4.21
2021-12-31 $20k 3.8k 5.25
2021-09-30 $23k 3.4k 6.68
2021-06-30 $15k 2.3k 6.67

More positions owned by Quadrant Capital

Ishares Tr Core S&p500 Etf (IVV)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Scp Etf (IJR)
Procter & Gamble Company (PG)
Ishares Core Msci Emkt (IEMG)
Amazon (AMZN)
Target Corporation (TGT)
Ishares Tr Eafe Sml Cp Etf (SCZ)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)

View all positions for Quadrant Capital

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
Paradigm Biocapital Advisors
Polygon Management
Cormorant Asset Management
Frazier Life Sciences Management
T. Rowe Price Associates
Perpetual
Lynx1 Capital Management
Perceptive Advisors
Bank of New York Mellon
Fred Alger Management
Laurion Capital Management
Walleye Trading Advisors
Alphabet

View all funds holding Autolus Therapeutics Plc spon ads